Clover Health Investments Management
Management criteria checks 3/4
Clover Health Investments' CEO is Andrew Toy, appointed in Jan 2023, has a tenure of 2.33 years. total yearly compensation is $9.48M, comprised of 7.6% salary and 92.4% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth $11.60M. The average tenure of the management team and the board of directors is 2.6 years and 4.2 years respectively.
Key information
Andrew Toy
Chief executive officer
US$9.5m
Total compensation
| CEO salary percentage | 7.61% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2.6yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026
May 11Clover Health Investments, Corp. (NASDAQ:CLOV) Could Be Riskier Than It Looks
May 09
Analysts Are Updating Their Clover Health Investments, Corp. (NASDAQ:CLOV) Estimates After Its First-Quarter Results
May 09
Tech-Driven Care And Home Services Will Secure Long-Term Success
Enhanced star ratings will increase future revenue and provide long-term stability due to improved financial benchmarks.Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Mar 07We Think Clover Health Investments (NASDAQ:CLOV) Can Afford To Drive Business Growth
Feb 25Clover Health: Undervalued Turnaround Play With Promising SaaS Potential
Jan 16Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
Dec 21Clover Health: Buy The Dip, Reap The Rewards
Nov 18Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
Nov 08Clover Health's Rally: The Payoff Of A Profitable Pivot
Nov 06There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03Clover Health: Changing Business Model, Seeking Profitability
Oct 03Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$24m |
| Dec 31 2024 | US$9m | US$721k | -US$46m |
| Sep 30 2024 | n/a | n/a | -US$96m |
| Jun 30 2024 | n/a | n/a | -US$121m |
| Mar 31 2024 | n/a | n/a | -US$154m |
| Dec 31 2023 | US$10m | US$700k | -US$210m |
| Sep 30 2023 | n/a | n/a | -US$226m |
| Jun 30 2023 | n/a | n/a | -US$268m |
| Mar 31 2023 | n/a | n/a | -US$344m |
| Dec 31 2022 | US$10m | US$500k | -US$255m |
| Sep 30 2022 | n/a | n/a | -US$443m |
| Jun 30 2022 | n/a | n/a | -US$402m |
| Mar 31 2022 | n/a | n/a | -US$615m |
| Dec 31 2021 | US$142m | US$450k | -US$588m |
| Sep 30 2021 | n/a | n/a | -US$527m |
| Jun 30 2021 | n/a | n/a | -US$487m |
| Mar 31 2021 | n/a | n/a | -US$160m |
| Dec 31 2020 | US$9m | US$415k | -US$136m |
| Sep 30 2020 | n/a | n/a | -US$89m |
| Jun 30 2020 | n/a | n/a | -US$145m |
| Mar 31 2020 | n/a | n/a | -US$272m |
| Dec 31 2019 | US$424k | US$400k | -US$364m |
Compensation vs Market: Andrew's total compensation ($USD9.48M) is above average for companies of similar size in the US market ($USD6.09M).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew Toy (45 yo)
Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 10.8yrs | no data | 18.14% $ 289.0m | |
| Co-Founder | 2.3yrs | US$9.48m | 0.73% $ 11.6m | |
| Chief Financial Officer | 1.3yrs | US$4.98m | 1.19% $ 18.9m | |
| Chief Executive Officer of Home Care | 2.8yrs | US$4.45m | 0.18% $ 2.8m | |
| Chief Executive Officer of Medicare Advantage | 2.3yrs | US$4.79m | 0.30% $ 4.8m | |
| CEO of Counterpart Health | less than a year | US$4.47m | 0.64% $ 10.2m | |
| Chief Compliance Officer | no data | no data | no data | |
| General Counsel | 1.6yrs | US$1.47m | 0.25% $ 4.0m | |
| Chief People Officer | no data | no data | no data | |
| Chief Medical Officer of Clover Assistant | 3.5yrs | no data | no data | |
| Chief Medical Officer | 4.3yrs | no data | no data | |
| Chief Executive Officer of Value Based Care | 3yrs | no data | 0.21% $ 3.4m |
Experienced Management: CLOV's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 10.8yrs | no data | 18.14% $ 289.0m | |
| Co-Founder | 6.5yrs | US$9.48m | 0.73% $ 11.6m | |
| Independent Director | 4.3yrs | US$283.88k | 0.11% $ 1.7m | |
| Independent Director | less than a year | US$147.53k | no data | |
| Independent Director | 8.3yrs | US$252.83k | 0.11% $ 1.7m | |
| Independent Director | 4.2yrs | US$275.34k | 0.090% $ 1.4m | |
| Independent Director | 2.8yrs | US$259.71k | 0.042% $ 667.4k | |
| Independent Director | 2.5yrs | US$259.25k | 0.11% $ 1.8m | |
| Lead Independent Director | 4.1yrs | US$287.05k | 0.092% $ 1.5m |
Experienced Board: CLOV's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/29 21:43 |
| End of Day Share Price | 2025/05/29 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Clover Health Investments, Corp. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kevin Fischbeck | BofA Global Research |
| Richard Close | Canaccord Genuity |
| Jason Cassorla | Citigroup Inc |